Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Azathioprine may help treat severe alopecia areata, but more research is needed.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A dermoscope helps accurately tell apart Pityrosporum folliculitis and Acne vulgaris.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

The document is a detailed medical reference on skin and genetic disorders.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

The document explains various skin conditions and their treatments.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Finasteride improved hidradenitis suppurativa in kids without side effects.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Hair loss was treated successfully with a special type of laser.